RecruitingEN originalGastric cancer

Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The primary objective is to determine whether pretreatment-to-posttreatment changes in circulating multigene methylation levels correlate with objective response rates (ORR) assessed by contrast-enhanced CT/MRI and levels of serum tumor markers. Secondary endpoints include: (a) time-dependent association between methylation fluctuation patterns and progression-free survival (PFS), (b) comparative diagnostic accuracy of methylation indices versus conventional biomarkers, and (c) feasibility of using methylation thresholds to guide adaptive therapy modification.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Wiek 18-75 lat w momencie rozpoznania
  • •Potwierdzony nowotwór żołądka lub połączenia żołądka z przełykiem
  • •Brak innych nowotworów w przeszłości
  • •Brak przerzutów do wątroby, płuc lub innych miejsc
  • •Bez wcześniejszego leczenia operacyjnego, chemioterapii lub immunoterapii
  • •Dostępne pełne dane medyczne i wyniki badań

✗ Disqualifies

  • •Oczekiwana długość życia poniżej 6 miesięcy
  • •Poważne zaburzenia psychiczne lub demencja
  • •Osoby ubezwłasnowolnione bez opiekuna prawnego
  • •Inne powody uznane przez lekarza prowadzącego badanie

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Maximum age
75 Years
Last updated (source)
August 27, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (2)

Tangdu Hospital

Xi'an, China

Xijing Hospital

Xi'an, China

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/28/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.